Sleep problems are considered a core symptom of depression. However, there is little information about the comorbidity of sleep problems and depression in low- and middle-income countries (LMICs), and whether sleep problems with depression confer additional risk for decrements in health compared to sleep problems alone. This study thus examined the association between sleep problems and depression and whether sleep problems with depression are associated with an increased risk for poorer health in 46 LMICs. Cross-sectional, community-based data from 237 023 adults aged ≥18 years from the World Health Survey (WHS) 2002–2004 were analyzed. Information on sleep problems (severe/extreme) and International Classification of Diseases 10th Revision depression/depression subtypes was collected. Multivariable logistic (binary and multinomial) and linear regression analyses were performed. Sleep problems were associated with subsyndromal depression (odds ratio [OR]: 2.23, 95% confidence interval [CI]: 1.84–2.70), brief depressive episode (OR = 2.48, 95% CI = 2.09–2.95) and depressive episode (OR = 3.61, 95% CI = 3.24–4.03). Sleep problems with depression (vs. sleep problems alone) conferred additional risk for anxiety, perceived stress and decrements in health in the domains of mobility, self-care, pain, cognition, and interpersonal activities. Clinicians should be aware that the co-occurrence of sleep problems and depression is associated with a variety of adverse health outcomes in LMICs. Detecting this co-occurrence may be important for treatment planning.
Sleep problems, which include difficulty in falling or staying asleep, early morning awakening with the non-resumption of sleep, and an inconsistent sleep/wake pattern1,2 are common in the general population. Studies from countries across the world have reported a prevalence of sleep problems ranging from 1.6% to 56.0%3,4,5, while other research has highlighted that sleep problems may be increasing in some countries/populations6,7,8. The fact that many people experience sleep problems is alarming given that they have been linked to a range of detrimental outcomes. Specifically, sleep problems have been associated with major medical conditions such as heart and lung disease, osteoporosis and bodily pain9, disability10, low quality of life11, while there is also evidence that insomnia may result in an increased mortality risk12,13.
Sleep problems have also been linked to various mental disorders, including depression14,15. Indeed, insomnia is considered a core symptom of depression16. Research has indicated that sleep problems/insomnia symptoms such as difficulty initiating and maintaining sleep and early morning awakening are common in mood disorders17 and that up to 90% of depressed patients may experience poor quality sleep18,19,20. Importantly, there is also a growing body of evidence that sleep problems may increase the risk for negative outcomes in the context of depression.Studies using data from both clinical and community samples have shown that insomnia/sleep disturbance is linked to a poorer quality of life21, functional impairment22, as well as an increased risk for suicidal behaviour23. There is also some indication that sleep difficulties may affect the course and outcome of depression as they have been linked to the severity of depression24,25, poor treatment outcomes (non-remittance)26,27, and depression recurrence in older adults28.
However, much of the research on the co-existence of sleep problems and depression has been undertaken in Western/high-income countries and there has been comparatively little systematic research on this comorbidity in low- and middle-income countries (LMICs). Two recent community-based studies among adults aged 50 and above in several LMICs found that there was a strong association between sleep problems and depression5,29. However, these studies were conducted in a limited number of LMICs and only focused on older adults. In addition, neither study assessed the association between sleep problems and different types of depression, or whether sleep problems comorbid with depression confer additional risk for adverse health outcomes compared to sleep problems alone.
Examining the comorbidity between sleep problems and depression is important in this setting as the prevalence of sleep problems has been reported to be high in many LMICs,3,5,29 while it has been estimated that over 80% of the non-fatal disease burden resulting from depression (Years Lived with Disability) occurred in LMICs in 201530. Findings from high-income countries may not be generalizable to LMICs as treatment for both sleep problems and depression is likely to be suboptimal in this setting given that few people receive even minimally adequate treatment for depression alone31 and the underlying causes of depression and sleep problems may differ. Indeed, a recent meta-analysis and systematic review has indicated that there is large geographic (continental) variation in the co-occurrence of sleep disturbance and depressive symptoms in older adults with it being much higher in Europe (18.3%) than Africa (4.5%)32. The need to understand the association between sleep problems and depression in this setting is given further impetus by the changes being brought by globalization and its accompanying social and economic challenges that might result in increased sleep problems in developing countries33. Moreover, as research from the US has indicated that sleep problems in depression are associated with both elevated direct (health care utilization) and indirect costs (e.g. lost work productivity)34, determining their association and combined effects in LMICs may have important clinical implications given their potential to place an even greater burden on health services21.
The current study thus had two aims: (i) to examine the association between sleep problems and different types of depression in community-dwelling individuals in LMICs; and (ii) to assess whether comorbid sleep problems and depression are associated with greater decrements in a variety of mental and physical health indicators as compared to sleep problems without depression in this setting.
Data and Methods
The World Health Survey (WHS) was a cross-sectional survey undertaken in 2002–2004 in 70 countries. Single-stage random sampling was carried out in 10 countries, while stratified multi-stage random cluster sampling was used in the other 60 countries. Survey details are available from the World Health Organization (WHO) (http://www.who.int/healthinfo/survey/en/). In brief, adults aged ≥18 years with a valid home address were eligible to participate. Kish tables were used to ensure that all household members had an equal chance of being selected. To ensure comparability across countries, the survey questionnaire was subject to standard translation procedures. Face-to-face interviews were conducted by trained interviewers. The individual response rate (ratio of completed interviews among selected respondents after excluding ineligible respondents from the denominator) ranged from 63% (Israel) to 99% (Philippines)35. Sampling weights were created using the population distribution as reported by the United Nations Statistical Division to adjust for survey non-response. Ethical boards at each study site provided ethical approval for the survey (see Supplementary Appendix 1) with all participants providing written informed consent. All methods were performed in accordance with relevant ethical guidelines and regulations.
Sleep problems were assessed by the question “Overall in the last 30 days, how much of a problem did you have with sleeping, such as falling asleep, waking up frequently during the night or waking up too early in the morning?” with answer options none, mild, moderate, severe, and extreme. Those who answered severe and extreme were considered to have sleep problems. This definition has been used in previous publications that have the same survey question on sleep problems3,5,29.
Severity of depressive symptoms
The severity of depressive symptoms was established based on the individual questions of the World Mental Health Survey version of the Composite International Diagnostic Interview (CIDI), which assessed the duration and persistence of depressive symptoms in the past 12 months36. Following the algorithms used in a previous WHS publication37, four mutually exclusive groups were established based on the ICD-10 Diagnostic Criteria for Research (ICD-10-DCR)38 where criterion B referred to symptoms of depressed mood, loss of interest, and fatigability. The algorithms used to define the four groups were the following:
Depressive episode group
At least two criterion B symptoms with a total of at least four depressive symptoms lasting two weeks most of the day or all of the day.
Brief depressive episode group
Same criteria as depressive episode but did not meet the two-week duration criterion.
At least one criterion B symptom with the total number of symptoms being three or less. A duration criterion of at least two weeks and presence of symptoms during most of the day had to be met.
No depressive disorder group
None of the above.
Any depression referred to having subsyndromal depression, brief depressive episode, or depressive episode.
Health status, perceived stress, anxiety, and observable mental illness
Health status was assessed with the use of 10 health-related questions pertaining to five different domains: (a) mobility; (b) self-care; (c) pain and discomfort; (d) cognition; (e) interpersonal activities. These domains correspond to frequently used health outcome measures included in the Short Form 12 (SF12)39, the Health Utilities Index Mark II and III (HUI)40 and the EUROQOL 5D41, and have been used as indicators of health status in prior studies with these data42,43. Each domain consisted of two questions that assessed health function in the past 30 days. Each item was scored on a five-point scale ranging from ‘none’ to ‘extreme/cannot do’. In accordance with previous WHS publications44,45, we assessed perceived stress in the last month with the use of two questions which were taken from the Perceived Stress Scale46. Each question was scored on a five-point scale which ranged from ‘never’ to ‘very often’. The actual questions used to assess health status and perceived stress can be found in Supplementary Appendix 2. For perceived stress and each separate domain for health status, we used factor analysis with polychoric correlations to obtain a factor score which was later converted to scores ranging from 0–10045 with higher values representing higher levels of perceived stress or worse health function. Anxiety was assessed by the question ‘Overall in the past 30 days, how much of a problem did you have with worry or anxiety’ with response options: none, mild, moderate, severe, and extreme. In accordance with previous WHS publications, those who answered severe and extreme were considered to have anxiety3,47. Observable mental illness was based on the interviewer’s subjective impression of the presence of mental health problems at the conclusion of the interview.
The control variables used in the analysis were selected based on past literature and included sex, age, education, wealth, residential location (rural or urban), physical activity, alcohol consumption, current smoking (no, non-daily, daily), obesity, and chronic physical conditions48,49. Education was based on the highest level of education attained (no formal education, primary education, secondary or high school completed, and tertiary education completed). Country-wise wealth quintiles were created using principal component analysis based on 15–20 assets depending on the country. Physical activity was assessed with the International Physical Activity Questionnaire, and was categorized as high, moderate, and low based on conventional cut-offs. Alcohol consumption was first assessed by the screening question ‘Have you ever consumed a drink that contains alcohol (such as beer, wine, etc.)?’ Respondents who replied negatively were considered lifetime abstainers. If the respondent replied affirmatively, then he/she was asked how many standard drinks of any alcoholic beverage he/she had on each day of the past seven days. The number of days in the past week on which four (female) or five (male) drinks were consumed was calculated, and a total of 1–2 days and three days or more in the past seven days were considered infrequent and frequent heavy drinking, respectively3. With the exception of lifetime abstainers, all other respondents were considered to be non-heavy drinkers. Obesity was defined as a body mass index of ≥30 kg/m2 based on self-reported weight and height. Seven chronic physical conditions (angina, arthritis, asthma, chronic back pain, diabetes, visual impairment, hearing problems) were assessed and those having at least one of the conditions were considered to have a chronic condition. Arthritis, asthma, and diabetes were based solely on self-reported lifetime diagnosis. For angina, in addition to a self-reported diagnosis, a symptom-based diagnosis based on the Rose questionnaire was also used50. Chronic back pain was defined as back pain (including disc problems) every day during the last 30 days. Visual impairment was defined as extreme difficulty in seeing and recognizing a person that the participant knows across the road (i.e., from a distance of about 20 meters)51. Hearing problems were considered to be present if the interviewer observed this condition at the conclusion of the survey.
From the 69 countries for which data were publicly available, 10 were excluded due to an absence of sampling information. Furthermore, 8 high-income countries were omitted as the short version of the questionnaire was administered in these countries and they lacked data on the majority of the variables used in this study. Spain and the United Arab Emirates were also omitted to focus on LMICs. Finally, Turkey, Latvia, and Morocco were excluded as data on some of the control variables were not collected. Thus, the final sample consisted of 237 023 individuals from 46 LMICs. Based on the World Bank classification at the time of the survey, this corresponded to 21 low-income countries (n = 105 286) and 25 middle-income countries (n = 131 737). The included countries and their sample size are shown in Supplementary Appendix 3. With the exception of China, Comoros, Congo, Ivory Coast, India, and Russia, these data are nationally representative.
Statistical analyses were performed with Stata 14.1 (Stata Corp LP, College station, Texas). Multivariable multinomial logistic regression analysis using the overall sample was conducted to assess the association between sleep problems (exposure) and the type of depression (outcome). Three models were constructed to assess the influence of the inclusion of different variables into the model on the sleep problem-depression relationship: Model 1 - adjusted for sociodemographic factors (age, sex, education, wealth, residential location, and country); Model 2 - adjusted for the variables in Model 1 and health behaviour (physical activity, alcohol consumption, smoking); Model 3 - adjusted for the variables in Model 2, obesity, and chronic physical conditions.
Next, in order to assess whether the association between sleep problems and any depression is consistent across countries, we conducted country-wise binary logistic regression analysis adjusting for age and sex. The estimates for each country were also combined into a random-effect meta-analysis with the Higgins’s I2 statistic being calculated. Higgins’s I2 represents the degree of heterogeneity between countries that is not explained by sampling error with a value of 25% often considered as low, 50% and above as moderate and over 75% as indicating high heterogeneity52.
Finally, we conducted separate multivariable linear regression analyses where each of the five health function domains and perceived stress were outcomes and a three-category variable based on a combination of sleep problems and any depression [(a) no sleep problems and no depression; (b) any sleep problems without depression; (c) any sleep problems with depression] was the exposure variable, as well as additional binary logistic regression analyses using observable mental illness and anxiety as the outcome. We used sleep problems without depression as the reference category as our main aim was to assess whether sleep problems with depression confers an additional risk for various health outcomes when compared with sleep problems in the absence of depression. We did not include those with depression without sleep problems in this part of the analysis for this same reason. Adjustment for age, sex, education, wealth, residential location, physical activity, alcohol consumption, smoking, obesity, chronic physical conditions, and country was done. Brazil, Hungary, and Zimbabwe were not included in the analysis with perceived stress as the outcome due to a lack of data.
Adjustment for country was conducted by including dummy variables for each country45. To avoid the omission of a large number of individuals from the regression analyses, a missing category was included only for obesity as 29.8% of the data was missing. Taylor linearization methods were used in all analyses to account for the sample weighting and complex study design. Results from linear and logistic regression analyses are presented as β-coefficients and odds ratios (ORs) respectively, with 95% confidence intervals (CIs). The level of statistical significance was p < 0.05.
The mean (SD) age of the participants was 38.4 (16.0) years; 50.8% were female. The sample characteristics are presented in Table 1. The prevalence of sleep problems and any depression was 7.5% and 11.7%, respectively. Sleep problems were much more common among those with all types of depression with a particularly high prevalence among those with a depressive episode [26.6% vs. 5.2% (no depression)] (Fig. 1). The multivariable analysis showed that sleep problems were significantly associated with all types of depression even after adjustment for sociodemographic factors, health behaviour, obesity, and chronic physical conditions (Model 3) (Table 2). Specifically, the ORs (95% CI) for subsyndromal depression, brief depressive episode, and depressive episode were 2.23 (1.84–2.70), 2.48 (2.09–2.95), and 3.61 (3.24–4.03), respectively (Model 3).
Country-wise analyses showed that sleep problems were significantly associated with any depression in all countries except Malawi. A moderately-high level of between-country heterogeneity was observed (I2 = 72.6%) with the pooled estimate based on a meta-analysis being OR = 4.43 (95% CI = 3.95–4.97) (Fig. 2). The association between different combinations of sleep problems and depression with a variety of health outcomes estimated by multivariable regression analyses is shown in Table 3. Sleep problems with depression was associated with significant decrements in all 5 health outcomes and higher levels of stress, observable mental illness and anxiety compared to sleep problems without depression.
This study showed that compared to individuals without sleeping difficulties, the prevalence of depression was significantly elevated in people with sleep problems. The odds for having subsyndromal depression among people with sleep problems more than doubled, and this odds ratio was 3.6 times higher for depressive episode. Sleep problems were associated with significantly increased odds for any depression in 45 of the 46 countries included in the study. Sleep problems with depression (vs. sleep problems alone) conferred additional risk for observable mental illness, anxiety, perceived stress and decrements in health status in the domains of mobility, self-care, pain, cognition, and interpersonal activities.
The finding that sleep problems were associated with significantly increased odds for depression concurs with earlier Western population-based studies which have linked sleep problems and depression/mood disorders in cross-sectional analyses53,54 It also accords with the results from previous cross-sectional studies undertaken in several LMICs among young33 and older adults5,29 which found that there was a strong association between sleep problems and depression, but that the strength of the association (as measured by the odds ratio) varied across countries5,29. The exact way in which poorer sleep and depression are linked is uncertain. Although insomnia/hypersomnia is classified as one of the symptoms of major depressive disorder (MDD) in DSM-516, findings from a number of recent prospective studies have indicated that insomnia may also be a risk factor for mental illness, including depression, in its own right14,55,56 and that the relationship between depression and insomnia might therefore be bidirectional57,58. A detailed discussion of the mechanisms underlying this association is beyond the scope of this paper although genetic59 and biological factors (e.g. dysregulation of the hypothalamic-pituitary-adrenal (HPA) axis)60 have both been proposed as being important in the association between sleep problems and depression. In addition, it has been suggested that problems in regulating emotions might also play a role in linking sleep problems and depression61.
As yet, the research on whether sleep problems and comorbid depression might have an especially detrimental impact on health and well-being has been somewhat limited. Thus, the finding that those with sleep problems and co-occurring depression had a significantly increased risk for a variety of negative health outcomes including worse cognition, mobility, greater pain and more perceived stress compared to individuals both without sleep problems or depression and with sleep problems but without depression has significant public health implications. Importantly, this result accords with those from several earlier studies which showed that individuals with comorbid sleep disorders/insomnia and depressive/mood disorders were more likely to have a lower quality of life62,63 and greater impairment in several (but not all) functional domains compared to those with no or less severe sleep problems22,64. It can only be speculated what underlies this finding. Previous research has indicated that sleep problems are associated with more severe depressive symptoms25 and possibly treatment resistance in depression65 both of which might be important for detrimental health outcomes. In addition, as both sleep problems15,66 and depression67 are independently associated with worse outcomes such as impaired role/social functioning, it is possible that when comorbid, their detrimental effects might be additive or synergistic.
This study has several strengths. It used data from mostly representative population samples from a large number of countries, which were collected using a common research methodology and instruments. In addition, it was also possible to examine a variety of outcomes while controlling for a number of covariates. Indeed, to the best of our knowledge it is the first study to examine the association between sleep problems and different forms of depression and how they are associated with various health outcomes in multiple LMICs. It should be acknowledged however, that there are also a number of study limitations. For practical considerations, information on sleep was not collected using polysomnography or actigraphy68 but was rather obtained from self-reports. However, there is evidence that depressed individuals may report some aspects of their sleep quality/problems inaccurately69,70. We also used a single-item question to collect information on sleep. Although this measure related to different sleep problems (difficulty falling asleep, waking at night and early morning awakening), we were not able to examine the effects of these sleep problems individually despite the fact that the strength of the depression-insomnia association may differ across different sleep problems57. It is also possible that variables were missing from the analysis that might have been influential in the observed associations. For example, childhood adversities have been linked to an increased risk for both poor quality sleep71 and depression72 in adulthood. Finally, as this study was cross-sectional it was not possible to establish causality or determine the order in which the observed associations occurred. Prospective research is now needed in LMICs to further elucidate the association between sleep problems and depression both in clinical and community-based samples and how they impact on health and well-being in these countries.
The finding that there is a strong association between sleep problems and depression in LMICs and that the comorbidity of these conditions is linked to an increased risk for a number of negative health outcomes highlights the importance of detecting and treating insomnia in depressed individuals in LMICs, especially as there is some evidence that interventions to improve sleep may have a rapid effect on depression73. In terms of this, a combined therapeutical approach is generally suggested for these comorbid conditions74 with research indicating that interventions such as cognitive-behavioural therapy for insomnia (CBT-I) and pharmacological treatments may be beneficial for depressed patients with sleep problems75,76,77. However, it should be recognized that the widespread adoption of such an approach may prove difficult given the many challenges involved in effectively treating mental illness and its comorbidities in resource-limited countries78. Given this, and other factors, such as the stigma attached to mental ill health78 that can prevent help-seeking behaviour, the fact that insomnia may be a prospective risk factor for depression and other negative health outcomes79, might indicate that early interventions for sleep problems may also be efficacious for mental health80 in LMICs.
The WHS is a dataset that is publicly available upon request.
Costa e Silva, J. A. Sleep disorders in psychiatry. Metabolism. 55, S40–44, https://doi.org/10.1016/j.metabol.2006.07.012 (2006).
Montgomery, P. & Dennis, J. A systematic review of non-pharmacological therapies for sleep problems in later life. Sleep Med Rev. 8, 47–62, https://doi.org/10.1016/S1087-0792(03)00026-1 (2004).
Koyanagi, A. & Stickley, A. The association between sleep problems and psychotic symptoms in the general population: a global perspective. Sleep. 38, 1875–1885, https://doi.org/10.5665/sleep.5232 (2015).
Leger, D., Poursain, B., Neubauer, D. & Uchiyama, M. An international survey of sleeping problems in the general population. Curr Med Res Opin. 24, 307–317, https://doi.org/10.1185/030079907X253771 (2008).
Stranges, S., Tigbe, W., Gomez-Olive, F. X., Thorogood, M. & Kandala, N. B. Sleep problems: an emerging global epidemic? Findings from the INDEPTH WHO-SAGE study among more than 40,000 older adults from 8 countries across Africa and Asia. Sleep. 35, 1173–1181, https://doi.org/10.5665/sleep.2012 (2012).
Alexander, M. et al. The National Veteran Sleep Disorder Study: descriptive epidemiology and secular trends, 2000–2010. Sleep. 39, 1399–1410, https://doi.org/10.5665/sleep.5972 (2016).
Hoyos, C., Glozier, N. & Marshall, N. S. Recent evidence on worldwide trends on sleep duration. Curr Sleep Medicine Rep. 1, 195–204 (2015).
Kronholm, E. et al. Trends in self-reported sleep duration and insomnia-related symptoms in Finland from 1972 to 2005: a comparative review and re-analysis of Finnish population samples. J Sleep Res. 17, 54–62, https://doi.org/10.1111/j.1365-2869.2008.00627.x (2008).
Foley, D., Ancoli-Israel, S., Britz, P. & Walsh, J. Sleep disturbances and chronic disease in older adults: results of the 2003 National Sleep Foundation Sleep in America Survey. J Psychosom Res. 56, 497–502, https://doi.org/10.1016/j.jpsychores.2004.02.010 (2004).
LaMonica, H. M. et al. Disability in older adults across the continuum of cognitive decline: unique contributions of depression, sleep disturbance, cognitive deficits and medical burden. Int Psychogeriatr. 1–15, https://doi.org/10.1017/S1041610218002144 (2019).
Hinz, A. et al. Sleep quality in the general population: psychometric properties of the Pittsburgh Sleep Quality Index, derived from a German community sample of 9284 people. Sleep Med. 30, 57–63, https://doi.org/10.1016/j.sleep.2016.03.008 (2017).
Li, Y. et al. Association between insomnia symptoms and mortality: a prospective study of U.S. men. Circulation. 129, 737–746, https://doi.org/10.1161/CIRCULATIONAHA.113.004500 (2014).
Parthasarathy, S. et al. Persistent insomnia is associated with mortality risk. Am J Med. 128, 268–275 e262, https://doi.org/10.1016/j.amjmed.2014.10.015 (2015).
Baglioni, C. et al. Insomnia as a predictor of depression: a meta-analytic evaluation of longitudinal epidemiological studies. J Affect Disord. 135, 10–19, https://doi.org/10.1016/j.jad.2011.01.011 (2011).
Roth, T. et al. Sleep problems, comorbid mental disorders, and role functioning in the national comorbidity survey replication. Biol Psychiatry. 60, 1364–1371, https://doi.org/10.1016/j.biopsych.2006.05.039 (2006).
American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders (5th Edition). (APA, 2013).
Rumble, M. E., White, K. H. & Benca, R. M. Sleep disturbances in mood disorders. Psychiatr Clin North Am. 38, 743–759, https://doi.org/10.1016/j.psc.2015.07.006 (2015).
Park, S. C. et al. Prevalence and clinical correlates of insomnia in depressive disorders: the CRESCEND study. Psychiatry Investig. 10, 373–381, https://doi.org/10.4306/pi.2013.10.4.373 (2013).
Riemann, D., Berger, M. & Voderholzer, U. Sleep and depression–results from psychobiological studies: an overview. Biol Psychol. 57, 67–103 (2001).
Tsuno, N., Besset, A. & Ritchie, K. Sleep and depression. J Clin Psychiatry. 66, 1254–1269 (2005).
Nutt, D., Wilson, S. & Paterson, L. Sleep disorders as core symptoms of depression. Dialogues Clin Neurosci. 10, 329–336 (2008).
Soehner, A. M. & Harvey, A. G. Prevalence and functional consequences of severe insomnia symptoms in mood and anxiety disorders: results from a nationally representative sample. Sleep. 35, 1367–1375, https://doi.org/10.5665/sleep.2116 (2012).
Malik, S. et al. The association between sleep disturbances and suicidal behaviors in patients with psychiatric diagnoses: a systematic review and meta-analysis. Syst Rev. 3, 18, https://doi.org/10.1186/2046-4053-3-18 (2014).
Mason, E. C. & Harvey, A. G. Insomnia before and after treatment for anxiety and depression. J Affect Disord. 168, 415–421, https://doi.org/10.1016/j.jad.2014.07.020 (2014).
Naismith, S. L. et al. Sleep disturbance relates to neuropsychological functioning in late-life depression. J Affect Disord. 132, 139–145, https://doi.org/10.1016/j.jad.2011.02.027 (2011).
Pigeon, W. R. et al. Is insomnia a perpetuating factor for late-life depression in the IMPACT cohort? Sleep. 31, 481–488 (2008).
Troxel, W. M. et al. Insomnia and objectively measured sleep disturbances predict treatment outcome in depressed patients treated with psychotherapy or psychotherapy-pharmacotherapy combinations. J Clin Psychiatry. 73, 478–485, https://doi.org/10.4088/JCP.11m07184 (2012).
Cho, H. J. et al. Sleep disturbance and depression recurrence in community-dwelling older adults: a prospective study. Am J Psychiatry. 165, 1543–1550, https://doi.org/10.1176/appi.ajp.2008.07121882 (2008).
Koyanagi, A. et al. Chronic conditions and sleep problems among adults aged 50 years or over in nine countries: a multi-country study. PLoS One. 9, e114742, https://doi.org/10.1371/journal.pone.0114742 (2014).
World Health Organization. Depression and Other Common Mental Disorders: Global Health Estimates. (WHO, 2017).
Thornicroft, G. et al. Undertreatment of people with major depressive disorder in 21 countries. Br J Psychiatry. 210, 119–124, https://doi.org/10.1192/bjp.bp.116.188078 (2017).
Bao, Y. P. et al. Cooccurrence and bidirectional prediction of sleep disturbances and depression in older adults: meta-analysis and systematic review. Neurosci Biobehav Rev. 75, 257–273, https://doi.org/10.1016/j.neubiorev.2017.01.032 (2017).
Peltzer, K. & Pengpid, S. Nocturnal sleep problems among university students from 26 countries. Sleep Breath. 19, 499–508, https://doi.org/10.1007/s11325-014-1036-3 (2015).
Bolge, S. C., Joish, V. N., Balkrishnan, R., Kannan, H. & Drake, C. L. Burden of chronic sleep maintenance insomnia characterized by nighttime awakenings among anxiety and depression sufferers: results of a national survey. Prim Care Companion J Clin Psychiatry. 12, https://doi.org/10.4088/PCC.09m00824gry (2010).
Moussavi, S. et al. Depression, chronic diseases, and decrements in health: results from the World Health Surveys. Lancet. 370, 851–858, https://doi.org/10.1016/S0140-6736(07)61415-9 (2007).
Kessler, R. C. & Ustun, T. B. The World Mental Health (WMH) Survey Initiative Version of the World Health Organization (WHO) Composite International Diagnostic Interview (CIDI). Int J Methods Psychiatr Res. 13, (93–121 (2004).
Ayuso-Mateos, J. L., Nuevo, R., Verdes, E., Naidoo, N. & Chatterji, S. From depressive symptoms to depressive disorders: the relevance of thresholds. Br J Psychiatry. 196, 365–371, https://doi.org/10.1192/bjp.bp.109.071191 (2010).
World Health Organization. The ICD–10 Classification of Mental and Behavioural Disorders: Diagnostic Criteria for Research. (WHO, 1993).
Ware, J. Jr., Kosinski, M. & Keller, S. D. A 12-item short-form health survey: construction of scales and preliminary tests of reliability and validity. Med Care. 34, 220–233 (1996).
Feeny, D., Furlong, W., Boyle, M. & Torrance, G. W. Multi-attribute health status classification systems. Health Utilities Index. Pharmacoeconomics. 7, 490–502 (1995).
Kind, P. In Quality of Life and Pharmacoeconomics in Clinical Trials (ed. Spiker, B.) 191–201 (Lippincott-Raven Publishers, 1996).
Nuevo, R. et al. The continuum of psychotic symptoms in the general population: a cross-national study. Schizophr Bull. 38, 475–485, https://doi.org/10.1093/schbul/sbq099 (2012).
Nuevo, R., Van, O. J., Arango, C., Chatterji, S. & Ayuso-Mateos, J. L. Evidence for the early clinical relevance of hallucinatory-delusional states in the general population. Acta Psychiatr Scand. 127, 482–493, https://doi.org/10.1111/acps.12010 (2013).
DeVylder, J. E. et al. Stress sensitivity and psychotic experiences in 39 low- and middle-income countries. Schizophr Bull. 42, 1353–1362, https://doi.org/10.1093/schbul/sbw044 (2016).
Vancampfort, D. et al. Perceived stress and its relationship with chronic medical conditions and multimorbidity among 229,293 community-dwelling adults in 44 low- and middle-income countries. Am J Epidemiol. 186, 979–989, https://doi.org/10.1093/aje/kwx159 (2017).
Cohen, S., Kamarck, T. & Mermelstein, R. A global measure of perceived stress. J Health Soc Behav. 24, 385–396 (1983).
Stubbs, B. et al. Physical activity and anxiety: a perspective from the World Health Survey. J Affect Disord. 208, 545–552, https://doi.org/10.1016/j.jad.2016.10.028 (2017).
Lippman, S. et al. Short sleep is associated with more depressive symptoms in a multi-ethnic cohort of older adults. Sleep Med. 40, 58–62, https://doi.org/10.1016/j.sleep.2017.09.019 (2017).
Poole, L. & Jackowska, M. The epidemiology of depressive symptoms and poor sleep: findings from the English Longitudinal Study of Ageing (ELSA). Int J Behav Med. 25, 151–161, https://doi.org/10.1007/s12529-017-9703-y (2018).
Rose, G. A. The diagnosis of ischaemic heart pain and intermittent claudication in field surveys. Bull World Health Organ. 27, 645–658 (1962).
Freeman, E. E. et al. The global burden of visual difficulty in low, middle, and high income countries. PLoS One. 8, e63315, https://doi.org/10.1371/journal.pone.0063315 (2013).
Higgins, J. P., Thompson, S. G., Deeks, J. J. & Altman, D. G. Measuring inconsistency in meta-analyses. BMJ. 327, 557–560, https://doi.org/10.1136/bmj.327.7414.557 (2003).
Jansson, M. & Linton, S. J. The role of anxiety and depression in the development of insomnia: cross-sectional and prospective analyses. Psychol Health. 21, 383–397, https://doi.org/10.1080/14768320500129015 (2006).
Stein, M. B., Belik, S. L., Jacobi, F. & Sareen, J. Impairment associated with sleep problems in the community: relationship to physical and mental health comorbidity. Psychosom Med. 70, 913–919, https://doi.org/10.1097/PSY.0b013e3181871405 (2008).
Li, L., Wu, C., Gan, Y., Qu, X. & Lu, Z. Insomnia and the risk of depression: a meta-analysis of prospective cohort studies. BMC Psychiatry. 16, 375, https://doi.org/10.1186/s12888-016-1075-3 (2016).
Pigeon, W. R., Bishop, T. M. & Krueger, K. M. Insomnia as a precipitating factor in new onset mental illness: a systematic review of recent findings. Curr Psychiatry Rep. 19, 44, https://doi.org/10.1007/s11920-017-0802-x (2017).
Alvaro, P. K., Roberts, R. M. & Harris, J. K. A systematic review assessing bidirectionality between sleep disturbances, anxiety, and depression. Sleep. 36, 1059–1068, https://doi.org/10.5665/sleep.2810 (2013).
Sivertsen, B. et al. The bidirectional association between depression and insomnia: the HUNT study. Psychosom Med. 74, 758–765, https://doi.org/10.1097/PSY.0b013e3182648619 (2012).
Gregory, A. M. et al. A longitudinal twin and sibling study of associations between insomnia and depression symptoms in young adults. Sleep. 39, 1985–1992, https://doi.org/10.5665/sleep.6228 (2016).
Benca, R. M. & Peterson, M. J. Insomnia and depression. Sleep Med. 9(Suppl 1), S3–9, https://doi.org/10.1016/S1389-9457(08)70010-8 (2008).
Baglioni, C., Spiegelhalder, K., Lombardo, C. & Riemann, D. Sleep and emotions: a focus on insomnia. Sleep Med Rev. 14, 227–238, https://doi.org/10.1016/j.smrv.2009.10.007 (2010).
Lai, Y. C. et al. Familiality and clinical outcomes of sleep disturbances in major depressive and bipolar disorders. J Psychosom Res. 76, 61–67, https://doi.org/10.1016/j.jpsychores.2013.10.020 (2014).
McCall, W. V., Reboussin, B. A. & Cohen, W. Subjective measurement of insomnia and quality of life in depressed inpatients. J Sleep Res. 9, 43–48, https://doi.org/10.1046/j.1365-2869.2000.00186.x (2000).
O’Brien, E. M. et al. Severe insomnia is associated with more severe presentation and greater functional deficits in depression. J Psychiatr Res. 45, 1101–1105, https://doi.org/10.1016/j.jpsychires.2011.01.010 (2011).
Sutton, E. L. Psychiatric disorders and sleep issues. Med Clin North Am 98, 1123–1143, https://doi.org/10.1016/j.mcna.2014.06.009 (2014).
Ten Have, M. et al. Insomnia among current and remitted common mental disorders and the association with role functioning: results from a general population study. Sleep Med. 25, 34–41, https://doi.org/10.1016/j.sleep.2016.07.015 (2016).
Kessler, R. C. et al. The epidemiology of major depressive disorder: results from the National Comorbidity Survey Replication (NCS-R). JAMA. 289, 3095–3105, https://doi.org/10.1001/jama.289.23.3095 (2003).
Ferrie, J. E., Kumari, M., Salo, P., Singh-Manoux, A. & Kivimaki, M. Sleep epidemiology–a rapidly growing field. Int J Epidemiol. 40, 1431–1437, https://doi.org/10.1093/ije/dyr203 (2011).
Argyropoulos, S. V. et al. Correlation of subjective and objective sleep measurements at different stages of the treatment of depression. Psychiatry Res. 120, 179–190, https://doi.org/10.1016/S0165-1781(03)00187-2 (2003).
Matousek, M., Cervena, K., Zavesicka, L. & Brunovsky, M. Subjective and objective evaluation of alertness and sleep quality in depressed patients. BMC Psychiatry. 4, 14, https://doi.org/10.1186/1471-244X-4-14 (2004).
Koskenvuo, K., Hublin, C., Partinen, M., Paunio, T. & Koskenvuo, M. Childhood adversities and quality of sleep in adulthood: a population-based study of 26,000 Finns. Sleep Med. 11, 17–22, https://doi.org/10.1016/j.sleep.2009.03.010 (2010).
Kessler, R. C. & Magee, W. J. Childhood adversities and adult depression: basic patterns of association in a US national survey. Psychol Med. 23, 679–690, https://doi.org/10.1017/S0033291700025460 (1993).
DeVylder, J. Sleep as an underused target for rapid response in the treatment of depression and suicidal ideation. Health Soc Work. 41, 211, https://doi.org/10.1093/hsw/hlw031 (2016).
Staner, L. Comorbidity of insomnia and depression. Sleep Med Rev. 14, 35–46, https://doi.org/10.1016/j.smrv.2009.09.003 (2010).
Manber, R. et al. Cognitive behavioral therapy for insomnia enhances depression outcome in patients with comorbid major depressive disorder and insomnia. Sleep. 31, 489–495 (2008).
McCall, W. V. et al. Treatment of insomnia in depressed insomniacs: effects on health-related quality of life, objective and self-reported sleep, and depression. J Clin Sleep Med. 6, 322–329 (2010).
Murphy, M. J. & Peterson, M. J. Sleep disturbances in depression. Sleep Med Clin. 10, 17–23, https://doi.org/10.1016/j.jsmc.2014.11.009 (2015).
Summergrad, P. Investing in global mental health: the time for action is now. Lancet Psychiatry. 3, 390–391, https://doi.org/10.1016/S2215-0366(16)30031-1 (2016).
Sivertsen, B. et al. Insomnia as a risk factor for ill health: results from the large population-based prospective HUNT Study in Norway. J Sleep Res. 23, 124–132, https://doi.org/10.1111/jsr.12102 (2014).
Baglioni, C., Spiegelhalder, K., Nissen, C. & Riemann, D. Clinical implications of the causal relationship between insomnia and depression: how individually tailored treatment of sleeping difficulties could prevent the onset of depression. EPMA J. 2, 287–293, https://doi.org/10.1007/s13167-011-0079-9 (2011).
A.K.’s work was supported by the Miguel Servet contract financed by the CP13/00150 and PI15/00862 projects, integrated into the National R + D + I and funded by the ISCIII - General Branch Evaluation and Promotion of Health Research - and the European Regional Development Fund (ERDF-FEDER). M.L. was supported by a grant from the Estonian Research Council (IUT5-1). Y.I. was supported by the Nippon Foundation International Fellowship program (http://intl-fellow.jp/). These organizations had no role in the study design, collection, analysis and interpretation; in the writing of the manuscript; and in the decision to submit the paper for publication.
The authors declare no competing interests.
Publisher’s note: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
About this article
Cite this article
Stickley, A., Leinsalu, M., DeVylder, J.E. et al. Sleep problems and depression among 237 023 community-dwelling adults in 46 low- and middle-income countries. Sci Rep 9, 12011 (2019). https://doi.org/10.1038/s41598-019-48334-7
This article is cited by
Severe sleep disturbance is associated with executive function impairment in patients with first-episode, treatment-naïve major depressive disorders
BMC Psychiatry (2021)
Self-reported suboptimal sleep and receipt of sleep assessment and treatment among persons with and without a mental health condition in Australia: a cross sectional study
BMC Public Health (2021)
A pilot investigation of accelerated deep transcranial magnetic stimulation protocols in treatment-resistant depression
European Archives of Psychiatry and Clinical Neuroscience (2021)
Sleep Disturbance and Its Association with Pain Severity and Multisite Pain: A Prospective 10.7-Year Study
Pain and Therapy (2020)